Jeffrey A Munsie's Net Worth
$172 Thousand
Who is Jeffrey A Munsie?
Jeffrey A Munsie does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include CONCERT PHARMACEUTICALS, INC., and MERRIMACK PHARMACEUTICALS INC.
SEC CIK
Jeffrey A Munsie's CIK is 0001703041
Past Insider Trading and Trends
2018 was Jeffrey A Munsie's most active year for acquiring shares with 2 total transactions. Jeffrey A Munsie's most active month to acquire stocks was the month of December. 2023 was Jeffrey A Munsie's most active year for disposing of shares, totalling 8 transactions. Jeffrey A Munsie's most active month to dispose stocks was the month of February. 2017 saw Jeffrey A Munsie paying a total of $0.00 for 550,000 shares, this is the most they've acquired in one year. In 2023 Jeffrey A Munsie cashed out on 297,477 shares for a total of $123,265.88, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
CONCERT PHARMACEUTICALS, INC. No price found
Chief Legal OfficerJeffrey A Munsie used to own units in Common Stock but no longer holds any shares there. From 2019 to 2023 Jeffrey A Munsie acquired a total of 113,616 shares in CONCERT PHARMACEUTICALS, INC., Jeffrey also disposed a total of 113,616 shares of CONCERT PHARMACEUTICALS, INC. equalling to $171,696.42.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -88.05K |
—
|
—
|
0
|
Mar 6
| |||
Form 4
| -4.10% | -3.76K |
$8.34 | -$31,375.08 | 88.05K |
Scheduled
|
Feb 15
| ||
Form 4
| -8.47% | -8.49K |
$8.35 | -$70,916.55 | 91.81K |
Scheduled
|
Jan 30
| ||
Form 4
| -2.80% | -2.89K |
$7.25 | -$20,974.25 | 100.3K |
Scheduled
|
Jan 6
| ||
Form 4
| -3.52% | -3.76K |
$3.09 | -$11,624.58 | 103.2K |
Scheduled
|
Feb 14
| ||
Form 4
| +147.25% | 63.7K |
—
|
—
| 106.96K |
Jan 28
| |||
Form 4
| -6.27% | -2.89K |
$3.20 | -$9,260.80 | 43.26K |
Scheduled
|
Jan 5
| ||
Form 4
| -7.54% | -3.76K |
$7.32 | -$27,545.16 | 46.15K |
Scheduled
|
Feb 16
| ||
Form 4
| +76.91% | 21.7K |
—
|
—
| 49.92K |
Jan 5
| |||
Form 4
|
∞
| 28.22K |
—
|
—
| 28.22K |
Feb 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 26
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
MERRIMACK PHARMACEUTICALS INC (MACK) Snapshot price: $13.05
General Counsel
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 6
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||